Tomer Mark

Tomer Mark

UNVERIFIED PROFILE

Are you Tomer Mark?   Register this Author

Register author
Tomer Mark

Tomer Mark

Publications by authors named "Tomer Mark"

Are you Tomer Mark?   Register this Author

66Publications

1434Reads

43Profile Views

Lessons learned from using a decision-support tool for precision placement of conservation practices in six agricultural watersheds in the US midwest.

J Environ Manage 2019 Jun 15;239:57-65. Epub 2019 Mar 15.

Department of Forestry & Natural Resources, Purdue University, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jenvman.2019.03.031DOI Listing
June 2019

Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma.

Am J Hematol 2019 May 25;94(5):539-545. Epub 2019 Feb 25.

Department of Medicine, Division of Hematology, University of Colorado School of Medicine, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25435DOI Listing
May 2019

Changes in lateral floodplain connectivity accompanying stream channel evolution: Implications for sediment and nutrient budgets.

Sci Total Environ 2019 Apr 7;660:1015-1028. Epub 2019 Jan 7.

United States Department of Agriculture Agricultural Research Service, National Laboratory for Agriculture and the Environment, 1015 N. University Blvd, Ames, IA 50011, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scitotenv.2019.01.038DOI Listing
April 2019

Phase 2 study of clarithromycin, pomalidomide, and dexamethasone in relapsed or refractory multiple myeloma.

Blood Adv 2019 02;3(4):603-611

Division of Hematology/Oncology, Department of Medicine, Weill Medical College of Cornell University, New York-Presbyterian Hospital, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2018028027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391672PMC
February 2019

Distribution and mass of groundwater orthophosphorus in an agricultural watershed.

Sci Total Environ 2018 Jun 12;625:1330-1340. Epub 2018 Jan 12.

USDA Agricultural Research Service, National Laboratory for Agriculture and Environment, Ames, IA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scitotenv.2018.01.035DOI Listing
June 2018

Incorporating monoclonal antibodies into the management of multiple myeloma.

Authors:
Tomer M Mark

Clin Adv Hematol Oncol 2017 Dec;15(12):919-922

University of Colorado School of Medicine, Aurora, Colorado.

View Article

Download full-text PDF

Source
December 2017

Monoclonal Antibodies in Multiple Myeloma: A New Wave of the Future.

Clin Lymphoma Myeloma Leuk 2017 09 27;17(9):545-554. Epub 2017 Jun 27.

Division of Hematology, University of Colorado Anschutz Medical Campus, Aurora, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.06.030DOI Listing
September 2017

A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma.

Biol Blood Marrow Transplant 2017 Jun 8;23(6):930-937. Epub 2017 Mar 8.

Department of Medicine, Division of Hematology/Oncology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.03.007DOI Listing
June 2017

Clonal plasma cells keep strange company.

Leuk Lymphoma 2016 4;57(4):744-5. Epub 2016 Jan 4.

a Division of Hematology and Oncology , Weill Cornell Medical College , New York , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1106539DOI Listing
August 2016

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma.

N Engl J Med 2016 Aug;375(8):754-66

From the Department of Hematology, University of Turin, Turin, Italy (A.P.); the Division of Hematology and Medical Oncology, Mayo Clinic Florida, Jacksonville (A.C.-K.); Universitaetsklinikum Tuebingen der Eberhard-Karls-Universitaet, Abteilung fuer Innere Medizin II, Tuebingen (K.W.), and University Medical Center of the Johannes Gutenberg-University, Third Department of Medicine, Mainz (M.M.) - both in Germany; Winship Cancer Institute, Emory University, Atlanta (A.K.N.); the Department of Hematology and Stem Cell Transplantation, St. László Hospital, Semmelweis University, Budapest, Hungary (T.M.); Ankara University, Department of Hematology, Ankara, Turkey (M.B.); Clinical Department of Hematology, 1st Medical Department, Charles University in Prague, Prague, Czech Republic (I.S.); Irmandade Da Santa Casa De Misericordia De São Paulo, São Paulo (V.H.); University Hospital of Salamanca-Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain (M.V.M.); Weill Cornell Medical College, New York (T.M.M.); Janssen Research and Development, Spring House, PA (M.Q., X.Q., T.A.); Janssen Research and Development, Raritan, NJ (J.S., H.A.); Janssen Research and Development, Beerse, Belgium (W.D.); Malignant Haematology and Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, VIC, Australia (A.S.); and the Department of Hematology, Erasmus MC, Rotterdam, the Netherlands (P.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1606038DOI Listing
August 2016

Allogeneic Transplantation for Patients With Advanced Myelofibrosis: Splenomegaly and High Serum LDH are Adverse Risk Factors for Successful Engraftment.

Clin Lymphoma Myeloma Leuk 2016 May 18;16(5):297-303. Epub 2016 Feb 18.

Division of Hematology and Medical Oncology, Weill Cornell Medical College, New York, NY; New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2016.02.004DOI Listing
May 2016

Practical Approaches to the Management of Dual Refractory Multiple Myeloma.

Curr Hematol Malig Rep 2016 Apr;11(2):148-55

University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 429, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-016-0312-7DOI Listing
April 2016

It's Time to Take Clarithromycin Seriously in Multiple Myeloma.

Acta Haematol 2016 28;135(2):101-2. Epub 2015 Oct 28.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000440874DOI Listing
February 2016

Novel Induction Regimens in Multiple Myeloma.

Curr Hematol Malig Rep 2015 Dec;10(4):388-94

Department of Medicine, Division of Hematology/Oncology, Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-015-0282-1DOI Listing
December 2015

Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study.

J Clin Oncol 2015 Nov 14;33(32):3741-9. Epub 2015 Sep 14.

Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.4015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737858PMC
November 2015

Diaphragmatic Amyloidosis Causing Respiratory Failure: A Case Report and Review of Literature.

Case Rep Oncol Med 2015 26;2015:917157. Epub 2015 Oct 26.

Department of Internal Medicine, New York Presbyterian Hospital, Weill Cornell Medical College, New York, NY 10065-4897, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2015/917157DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637487PMC
November 2015

Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.

Biol Blood Marrow Transplant 2015 Oct 3;21(10):1808-14. Epub 2015 Jul 3.

New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, New York; Division of Hematology and Medical Oncology, Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.06.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568152PMC
October 2015

Pulmonary hypertension complicating multiple myeloma.

Pulm Circ 2015 Sep;5(3):590-7

Division of Cardiology, Weil Cornell Medical College, New York Presbyterian Hospital-Cornell Medical Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/682430DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556512PMC
September 2015

Thalidomide, clarithromycin, lenalidomide and dexamethasone therapy in newly diagnosed, symptomatic multiple myeloma.

Leuk Lymphoma 2014 Dec 25;55(12):2842-9. Epub 2014 Mar 25.

Center of Excellence for Lymphoma and Myeloma, Weill Medical College of Cornell University, New York Presbyterian Hospital , New York, NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.896005DOI Listing
December 2014

Controversies in multiple myeloma: to transplant or not?

Curr Hematol Malig Rep 2014 Dec;9(4):360-7

Department of Medicine, Division of Hematology and Oncology, Mount Sinai Beth Israel, 16th street and 1st avenue, New York, NY, 10003, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-014-0230-5DOI Listing
December 2014

Potential role of daratumumab in the treatment of multiple myeloma.

Onco Targets Ther 2014 18;7:1095-100. Epub 2014 Jun 18.

Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York Presbyterian Hospital-Cornell Medical Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://www.dovepress.com/potential-role-of-daratumumab-in-th
Publisher Site
http://dx.doi.org/10.2147/OTT.S49480DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069139PMC
June 2014

Preclinical and clinical results with pomalidomide in the treatment of relapsed/refractory multiple myeloma.

Leuk Res 2014 May 13;38(5):517-24. Epub 2014 Mar 13.

Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York Presbyterian Hospital - Cornell Medical Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2014.02.008DOI Listing
May 2014

Management of double-refractory multiple myeloma.

Curr Hematol Malig Rep 2013 Dec;8(4):253-60

Department of Internal Medicine, University of Hawaii, 1356 Lusitana St. 7th Floor, Honolulu, HI, 96813, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-013-0173-2DOI Listing
December 2013

Pomalidomide: new immunomodulatory agent with potent antiproliferative effects.

Crit Rev Oncol Hematol 2013 Oct 17;88 Suppl 1:S36-44. Epub 2013 Jun 17.

Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2013.02.001DOI Listing
October 2013

Pomalidomide in the treatment of relapsed multiple myeloma.

Future Oncol 2013 Jul;9(7):939-48

Division of Hematology & Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York Presbyterian Hospital-Cornell Medical Center, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.13.105DOI Listing
July 2013

A phase 1 study of bendamustine and melphalan conditioning for autologous stem cell transplantation in multiple myeloma.

Biol Blood Marrow Transplant 2013 May 20;19(5):831-7. Epub 2013 Feb 20.

Department of Medicine, Division of Hematology and Oncology, Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.02.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3985064PMC
May 2013

BiRd (clarithromycin, lenalidomide, dexamethasone): an update on long-term lenalidomide therapy in previously untreated patients with multiple myeloma.

Blood 2013 Mar 8;121(11):1982-5. Epub 2013 Jan 8.

Division of Hematology and Medical Oncology, Department of Medicine, Myeloma Center, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2012-08-44
Publisher Site
http://dx.doi.org/10.1182/blood-2012-08-448563DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596960PMC
March 2013

Treatment with lenalidomide and dexamethasone in patients with multiple myeloma and renal impairment.

Cancer Treat Rev 2012 Dec 18;38(8):1012-9. Epub 2012 May 18.

Department of Clinical Therapeutics, University of Athens School of Medicine, Alexandra Hospital, 80 Vas. Sofias, Athens 11528, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2012.02.009DOI Listing
December 2012

Sediment removal by prairie filter strips in row-cropped ephemeral watersheds.

J Environ Qual 2012 Sep-Oct;41(5):1531-9

Department of Agricultural and Biosystems Engineering, Iowa State University, Ames, IA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2134/jeq2011.0473DOI Listing
December 2012

Factor VIII/von Willebrand factor concentrate therapy for ventricular assist device-associated acquired von Willebrand disease.

Transfusion 2012 Jul 9;52(7):1535-41. Epub 2012 Jan 9.

Department of Pathology and Laboratory Medicine, Weill Cornell Medical Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1537-2995.2011.03500.xDOI Listing
July 2012

Perennial filter strips reduce nitrate levels in soil and shallow groundwater after grassland-to-cropland conversion.

J Environ Qual 2010 Nov-Dec;39(6):2006-15

Dep. of Agricultural and Biosystems Engineering, Iowa State Univ., Ames, IA 50011, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2134/jeq2010.0151DOI Listing
February 2011

Phase 2 trial of the histone deacetylase inhibitor romidepsin for the treatment of refractory multiple myeloma.

Cancer 2011 Jan 22;117(2):336-42. Epub 2010 Sep 22.

Department of Medicine, Division of Hematology Oncology, Center of Excellence of Lymphoma and Myeloma, Weill Cornell Medical College/New York Presbyterian Hospital, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25584DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010462PMC
January 2011

Best practices in the management of newly diagnosed multiple myeloma patients who will not undergo transplant.

Oncology (Williston Park) 2010 Mar;24(3 Suppl 2):14-21

Weill Cornell Medical College, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
March 2010

Novel agents in myeloma: an exciting saga.

Cancer 2009 Jan;115(2):236-42

Division of Hematology and Medical Oncology, Department of Medicine, Center of Lymphoma and Myeloma, Weill Medical College of Cornell University, New York Presbyterian Hospital-Cornell Medical Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.24040
Publisher Site
http://dx.doi.org/10.1002/cncr.24040DOI Listing
January 2009

Milatuzumab: a promising new agent for the treatment of lymphoid malignancies.

Expert Opin Investig Drugs 2009 Jan;18(1):99-104

Weill Medical College of Cornell University, New York Presbyterian Hospital-Cornell Medical Center, Center for Lymphoma and Myeloma, Division of Hematology and Medical Oncology, 525 East 68th Street, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543780802636162DOI Listing
January 2009

Atypical serum immunofixation patterns frequently emerge in immunomodulatory therapy and are associated with a high degree of response in multiple myeloma.

Br J Haematol 2008 Dec 16;143(5):654-60. Epub 2008 Oct 16.

Department of Medicine, Division of Hematology and Medical Oncology, Center of Lymphoma and Myeloma, Weill Medical College of Cornell University, New York Presbyterian Hospital-Cornell Medical Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2008.07374.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626496PMC
December 2008

Stem cell mobilization with cyclophosphamide overcomes the suppressive effect of lenalidomide therapy on stem cell collection in multiple myeloma.

Biol Blood Marrow Transplant 2008 Jul;14(7):795-8

Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York Presbyterian Hospital-Cornell Medical Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2008.04.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626097PMC
July 2008

Groundwater nitrate following installation of a vegetated riparian buffer.

Sci Total Environ 2007 Oct 27;385(1-3):297-309. Epub 2007 Jul 27.

National Institute of Public Health, 2-3-6, Minami, Wako, Saitama 351-0197 Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scitotenv.2007.06.035DOI Listing
October 2007

Lenalidomide-induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment-naïve patients undergoing front-line lenalidomide and dexamethasone therapy.

Br J Haematol 2007 Sep;138(5):640-3

Center of Excellence for Lymphoma and Myeloma, Division of Hematology and Medical Oncology, Weill Medical College of Cornell University, New York Presbytarian Hospital-Cornell Medical Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1365-2141.2007.06698.x
Publisher Site
http://dx.doi.org/10.1111/j.1365-2141.2007.06698.xDOI Listing
September 2007